Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Agree, and this also implies that it is likely an AXAL deal will follow, then a HOT deal. HER2 for pediatric osteosarcoma has not even begun a phase 1 trial, and now we have a partner paying for it all, whereas AXAL for cervical cancer has already completed a phase 1 and phase 2 and is in an ongoing Phase 3, so look for an AXAL partner next.

Way to go Ken Berlin. You are aligned with us and a real CEO.

Ken Berlin = ROI focused, fiscal restraint, alignment, leadership, intelligent business strategy, mentality of "I win only if my investors win"

Dan O'Connor = "me" focused, fiscal recklessness, showmanship, no substance, weak business strategy and execution, unethical, mentality of "I win at the expense of my investors"